Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Genes, Chromosomes and Cancer

• Publication date

  1999-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1098-2264(199908)25:4<307::AID-GCC1>3.0.CO;2-1PMID 10398423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in Brief Comparative Genomic in Situ Hybridization of Colon Carcinomas with Replication Error '

  2006cited by this paper
• Comparative genomic hybridization: a comparison with molecular and cytogenetic analysis.

  1998cited by this paper
• Karyotypic analysis of 32 malignant epithelial ovarian tumors.

  1997cited by this paper
• Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: Clinicopathological correlations

  1997cited by this paper
• Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas

  1997cited by this paper
• Detection of DNA gains and losses in primary endometrial carcinomas by comparative genomic hybridization

  1997cited by this paper
• Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.

  1997cited by this paper
• Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix.

  1996cited by this paper
• Frequent microsatellite instability in epithelial borderline ovarian tumors.

  1996cited by this paper
• Microsatellite instability differences between familial and sporadic ovarian cancers.

  1996cited by this paper
• Detection of numerical chromosome anomalies in interphase cells of ovarian carcinomas using fluorescence in situ hybridization

  1996cited by this paper
• Borderline ovarian tumors.

  1996cited by this paper
• The relationship between borderline ovarian tumors and epithelial ovarian carcinoma: epidemiologic, pathologic, and molecular aspects.

  1996cited by this paper
• Genomic instability in ovarian cancer: a reassessment using an arbitrarily primed polymerase chain reaction.

  1996cited by this paper
• Origins of heterogeneous ovarian carcinomas. A molecular cytogenetic analysis of histologically benign, low malignant potential, and fully malignant components.

  1996cited by this paper
• Karyotypic characteristics of borderline malignant tumors of the ovary: trisomy 12, trisomy 7, and r(1) as nonrandom features.

  1996cited by this paper
• DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.

  1996cited by this paper
• Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer

  1996cited by this paper
• Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors

  1996cited by this paper
• Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas.

  1996cited by this paper
• Comparative Cytogenetic Studies of Benign, Borderline, and Malignant Epithelial Ovarian Tumors

  1996cited by this paper
• Quantitative analysis of comparative genomic hybridization.

  1995cited by this paper
• Genetic analysis of benign, low-grade, and high-grade ovarian tumors.

  1995cited by this paper
• Computer image analysis of comparative genomic hybridization.

  1995cited by this paper
• Recurrent cytogenetic aberrations in human ovarian carcinomas.

  1995cited by this paper
• Comparative genomic in situ hybridization of colon carcinomas with replication error.

  1995cited by this paper
• Comparative genomic hybridization: an overview.

  1994cited by this paper
• Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma

  1994cited by this paper
• Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.

  1994cited by this paper
• Early de novo ovarian carcinoma. A study of fourteen cases

  1994cited by this paper
• Clonal chromosome abnormalities in 54 cases of ovarian carcinoma.

  1994cited by this paper
• Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors.

  1994cited by this paper
• Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.

  1993cited by this paper
• Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization

  1993cited by this paper
• Cytogenetic studies of epithelial ovarian carcinoma.

  1993cited by this paper
• Chromosome aberrations in 35 primary ovarian carcinomas

  1992cited by this paper
• Current concepts in epithelial ovarian tumors: does benign to malignant transformation occur?

  1992cited by this paper
• Trisomy 12 and K‐ras‐2 Amplification in human ovarian tumors

  1991cited by this paper
• Numerical chromosome abnormalities associated with early clinical stages of gynecologic tumors.

  1991cited by this paper
• Simple numerical chromosome aberrations in well-differentiated malignant epithelial tumors.

  1990cited by this paper
• Cytogenetic study of solid ovarian tumors.

  1990cited by this paper
• Protooncogene amplification and tumor ploidy in human ovarian neoplasms.

  1990cited by this paper

• High Grade Serous Cystadenocarcinoma of Testis-Case Report of a Rare Ovarian Epithelial Type Tumour.

  2017cites this paper
• Ovarian-type epithelial tumours of the testis: immunohistochemical and molecular analysis of two serous borderline tumours of the testis

  2015cites this paper
• Tumors of the Female Genital Organs

  2015cites this paper
• Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours

  2011cites this paper
• 16. Tumors of the Female Genital Organs

  2010cites this paper
• Immunohistochemical analysis of hMLH1 and hMSH2 proteins in serous ovarian tumours.

  2010cites this paper
• Proteomic analysis of cell models of ovarian cancer tumour suppression

  2010cites this paper
• Genomic aberrations in borderline ovarian tumors

  2010cites this paper
• Genetic alterations detected by comparative genomic hybridization and recurrence rate in epithelial ovarian carcinoma.

  2009cites this paper
• Genomic Markers for Ovarian Cancer at Chromosomes 1, 8 and 17 Revealed by Array CGH Analysis

  2009cites this paper
• Gross genomic alterations differ between serous borderline tumors and serous adenocarcinomas—an image cytometric DNA ploidy analysis of 307 cases with histogenetic implications

  2009cites this paper
• Genome profiling of ovarian adenocarcinomas using pangenomic BACs microarray comparative genomic hybridization

  2008cites this paper
• Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target

  2008cites this paper
• Biomarker Discovery in Ovarian Cancer

  2008cites this paper
• Serous borderline ovarian tumors in long-term culture: phenotypic and genotypic distinction from invasive ovarian carcinomas

  2007cites this paper
• Biomarker discovery in epithelial ovarian cancer by genomic approaches.

  2007cites this paper
• Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors.

  2006cites this paper
• OPCML and the IgLON family : expression, function and links with ovarian cancer

  2006cites this paper
• Correlations between c-myc gene copy-number and clinicopathological parameters of ovarian tumours.

  2006cites this paper
• Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas.

  2006cites this paper
• In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer.

  2005cites this paper
• Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer

  2005cites this paper
• The use of cytogenetics in understanding ovarian cancer.

  2004cites this paper
• STK15 polymorphisms and association with risk of invasive ovarian cancer.

  2004cites this paper
• Comparative study of primary and recurrent ovarian serous carcinomas: comparative genomic hybridization analysis with a potential application for prognosis.

  2003cites this paper
• Cancer of the Ovary and Fallopian Tube

  2003cites this paper
• Analysis of microsatellite instability and X-inactivation in ovarian borderline tumors lacking numerical abnormalities by comparative genomic hybridization.

  2003cites this paper
• Familial vs sporadic ovarian tumors: characteristic genomic alterations analyzed by CGH.

  2003cites this paper
• Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas.

  2002cites this paper
• Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization.

  2002cites this paper
• Genomic imbalances in ovarian borderline serous and mucinous tumors.

  2002cites this paper
• FISH detection of HER2 amplification in breast cancer.

  2002cites this paper
• Compilation of published comparative genomic hybridization studies.

  2002cites this paper
• Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays.

  2002cites this paper
• Comparative Genome Hybridization

  2002cites this paper
• Allelic imbalance is not restricted to numerically abnormal chromosomes in epithelial ovarian tumours

  2001cites this paper
• Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms.

  2001cites this paper
• Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors.

  2001cites this paper
• Serous tumors of low malignant potential of the ovary-molecular pathology: part 2

  2001cites this paper
• Molecular and cytogenetic changes in ovarian carcinoma

  2001cites this paper
• Molecular genetics of ovarian cancer

  2001cites this paper
• [Phenotype--genotype--correlation in ovarian neoplasia].

  2001cites this paper
• Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel.

  2000cites this paper
• Patterns of genomic imbalances in human solid tumors (Review).

  2000cites this paper
• New developments in the analysis of gene expression

  2000cites this paper
• DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: detection of numerical and structural chromosome aberrations.

  2000cites this paper